Getting Your Patents Licensed or Acquired: What Actually Works?
- 1 day ago
- 7 min read
Most patents sit in a drawer. That is not an exaggeration or a cynical jab at inventors. Studies of patent utilization have found that somewhere between 80 and 95 percent of issued patents are never licensed, sold, or asserted. They are filed, maintained at real cost, and then quietly abandoned when the renewal fees stop feeling worth it. If you are building or managing a patent portfolio and you actually want it to generate revenue, either through licensing or through a sale, you need to treat that outcome as something you engineer for from day one, not something you hope happens after the fact.
Here is what separates the portfolios that get licensed or bought from the ones that gather dust.
Start With Value, Not Just Novelty
Patent examiners care about novelty and non-obviousness. Buyers and licensees care about none of that directly. They care about whether the patent covers something they need, something they are already doing, or something they are worried a competitor will do. A patent can be perfectly valid and completely unwanted.
The clearest illustration of this is the Cohen-Boyer patent, filed by Stanford University and the University of California, San Francisco in the 1970s, covering the basic technique of recombinant DNA. Stanford's licensing office did not wait for companies to come knocking. They identified early on that this was foundational technology for an entire coming industry and built a licensing program around it before biotech even existed as a recognizable sector. The patent went on to generate around 255 million dollars in licensing revenue over its life, spread across more than 468 companies. The lesson is not "invent something foundational," which is obviously easier said than done. The lesson is that Stanford treated the patent as a business asset from the start, actively identifying who would need it and building relationships with that audience well before litigation or desperation entered the picture.
Contrast that with the graveyard of "patent troll" portfolios built purely around litigation value rather than technical usefulness. Those can generate settlements, but they rarely generate durable licensing relationships, and they tend to poison the market for the patent holder's other assets. If your strategy is "sue first, license later," you are not building a portfolio anyone wants to acquire. You are building a liability that scares off legitimate buyers.
Map Your Patents to Real Products, Not Just Claims
A patent that only exists on paper, disconnected from any product or standard, is much harder to license because a prospective licensee has to do the work of figuring out whether they even need it. The patents that get licensed most easily are the ones tied to something concrete: a component in a widely used product, a step in a manufacturing process, or a feature that shows up in an industry standard.
This is why standard-essential patents, the ones incorporated into technical standards like Wi-Fi, Bluetooth, or cellular protocols, are some of the most consistently licensed patents in existence. Qualcomm built an entire business model around this. By getting its CDMA and later LTE-related patents embedded into the technical standards that every phone manufacturer had to implement, Qualcomm made licensing almost automatic. You cannot build a compliant phone without touching patented technology that Qualcomm holds, so manufacturers pay the licensing fee as a cost of entry. That is an extreme version of the strategy, and it came with its own regulatory scrutiny over the years, but the underlying principle scales down to any portfolio: if you can get your patented technology adopted as part of a standard, a common manufacturing process, or a widely used design pattern, you have effectively created your own market of forced licensees.
If standard-setting is out of reach, the more modest version of this is simple. Before you file, ask who would actually build a product using this claim. If you cannot name three or four companies, divisions, or product lines that would infringe by doing business as usual, the patent is going to be a hard sell.
Keep the Portfolio Clean and Well Documented
Buyers and licensees run diligence. A portfolio riddled with unclear inventorship, missed maintenance fee deadlines, unclear chain of title, or claims that were never properly prosecuted will kill deals before negotiations even start. This sounds like basic housekeeping, and it is, but it is the single most common reason licensing and acquisition conversations fall apart after they have already begun.
When Kodak sold roughly 1,100 imaging patents in 2013 to a consortium that included Apple, Google, Microsoft, Adobe, and others, that deal happened only after an extensive and painful diligence process during the company's bankruptcy proceedings. Kodak had spent decades building genuinely important digital imaging patents, but the sale price ended up well below what analysts had originally projected, in part because buyers spent the process picking apart claim quality and validity rather than simply writing a check for the portfolio's assumed strategic value. A cleaner, better documented portfolio going into that process likely would have closed faster and for more money.
Practically, this means keeping your assignment records current, tracking prosecution history clearly, maintaining a simple internal database of what each patent covers and which products or use cases it maps to, and paying maintenance fees on time for anything you intend to keep. It is unglamorous work, and it is exactly the kind of thing that gets neglected in growing companies where the legal team is stretched thin. Do not let that happen to the patents you actually care about monetizing.
Build Relationships Before You Need Them
The best licensing and acquisition deals rarely start with a cold outreach email offering a patent for sale. They start with relationships that already exist, whether through industry conferences, joint research, prior licensing deals, or simply being visible in the right technical communities.
IBM has run the most consistently profitable corporate patent licensing program for decades, generating well over a billion dollars a year in licensing revenue during its peak years. Part of how they did it was sheer volume, IBM has led the list of annual US patent grant recipients for close to three decades running. But volume alone does not explain the revenue. IBM built a dedicated licensing organization whose entire job was staying in contact with potential licensees across the electronics and computing industries, understanding what those companies were building, and proactively structuring deals, including broad cross-licenses, before disputes ever needed to happen. Their licensing team functioned less like a law firm sending cease and desist letters and more like a sales organization with deep technical fluency.
You do not need IBM's scale to apply the same logic. If you are a smaller portfolio holder, this might mean attending the trade shows your target licensees attend, publishing technical material that puts your name in front of the right engineers, or simply reaching out to business development contacts at companies in your space well before you have any specific ask. When the moment comes to actually offer a license, you want to be a known, credible party rather than a stranger asking for money.
Consider a Broker or Aggregator, But Know What You Are Trading Away
Intellectual Ventures built its entire business on aggregating patents from individual inventors, universities, and struggling companies, then licensing that combined portfolio to large operating companies. For patent holders who lack the resources or relationships to run a licensing program themselves, selling into an aggregator, or working with a patent broker on a commission basis, can be the fastest route to actual revenue.
The tradeoff is real. You typically get a smaller share of the eventual licensing revenue than you would if you ran the program yourself, and you give up control over how and to whom the patent gets licensed or asserted. Some patent holders have been unhappy to discover their patents used more aggressively in litigation than they intended once handed over. If reputation matters to you, particularly if you are a university or a company that still sells products in the same space, read any brokerage or assignment agreement carefully for language about litigation strategy and public attribution.
For many smaller holders, though, this route beats the alternative of a portfolio that never gets used at all. A smaller percentage of actual revenue is worth more than a larger percentage of nothing.
Time the Market
Acquisition value for patent portfolios moves with industry sentiment, and sentiment can shift fast. The Nortel patent auction in 2011 is the textbook case. As Nortel went through bankruptcy, a consortium including Apple, Microsoft, RIM, and Ericsson paid 4.5 billion dollars for roughly 6,000 patents covering wireless and networking technology, a price that stunned most observers at the time and was roughly five times the opening bid. That price reflected a specific moment of intense competitive anxiety in the smartphone patent wars, with companies actively worried about being shut out of the market by rivals' patent positions.
Portfolios covering similar ground sold for far less just a few years later once that particular wave of litigation anxiety cooled off. If you are holding patents in a fast moving technical area, pay attention to what is happening competitively in that space. A portfolio that looks defensively necessary to three or four major players simultaneously will command a very different price than the same portfolio offered during a quiet period.
The Common Thread
None of these examples share a single trick. What they share is treating the patent portfolio as a business asset that needs active management, not a legal artifact that takes care of itself once granted. That means picking claims tied to real products, keeping records clean enough to survive diligence, building relationships with likely licensees before you need them, being honest about whether you need a broker's help, and paying attention to timing rather than treating every year as equally good for a sale.
Patents that get licensed or acquired are patents that someone worked to make licensable. That work usually starts years before the deal, and it rarely looks as exciting as the eventual headline number.
Comments